Techstars & BrightEdge: Partnering with health systems in the era of AI

​The AI era is here. Is your company ready for the health system?

​In the rapidly evolving AI landscape, the gap between a great product and clinical integration is wider than ever. Join us for a high-intensity, 30-minute session designed for founders seeking to bridge the gap between startup agility and institutional scale.

​We’ve brought together a team of innovation leaders from Mass General Brigham, MedStar Health, ACS BrightEdge, and Techstars AI Health, to discuss exactly what health systems consider when building, integrating, and adopting AI technology. This is your chance to hear directly from the leaders who source, fund, and implement healthcare innovation.

Speakers:

• ​Michael Freni (Mass General Brigham)

• ​Dr. Dan Marchalik (MedStar Health)

• ​Nate Macht (ACS BrightEdge)

• ​Nick Culbertson (Techstars AI Health Baltimore)

​Who Should Join: Early stage startup founders or health care experts with startup aspirations.

About BrightEdge

​BrightEdge is the American Cancer Society's donor-funded innovation and impact investment arm that invests in for-profit companies developing therapeutics, diagnostics, medical devices, and technologies to support ACS’s mission to end cancer as we know it, for everyone. It invests alongside top-tier life sciences and healthcare investors with a goal of generating financial returns and patient impact. For more information and a copy of the fund's annual report, visit www.acsbrightedge.org.

About Techstars AI Health

​Techstars AI Health Baltimore is Techstars’ flagship healthcare accelerator, investing $220,000 per company into AI-driven health startups building solutions that improve healthcare economics and patient outcomes. Powered by our region's top payor, provider, and academic institutions, we focus relentlessly on helping companies demonstrate measurable commercial traction, because in healthcare, ROI drives adoption.